TNL Mediagene (TNMG)

TNL Mediagene is a Tokyo-based media company with operations in Taiwan and Japan. Its portfolio includes a range of digital news, lifestyle, business, technology, and culture properties such as The News Lens, Business Insider Japan, Business Yee, DIGIDAY JAPAN, GLOSSY JAPAN, Gizmodo Japan, Cool3c, Tech Insider, INSIDE, iCook, Lifehacker Japan, ROOMIE, every little d, Sports Vision, Agent Movie, Fuze, and Sirabee. The company also operates event, conference, and specialized content businesses, alongside activities in artificial intelligence, advertising technology, digital studio services, and e-commerce. TNL Mediagene is listed on NASDAQ under the ticker TNMG as common stock.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-TNMG
$3.61
-6.8% Downside
Fair
$112 2,794.1% Upside
Not available
Bargain
Weak
0.0%
1.237 M
18.734 M
94.2%
74.3%
-36.1
13.4%
Valuation • Fair Value

TNL Mediagene (NASDAQ-TNMG) Fair Value by Valuation Model

Review the available estimates for TNL Mediagene (NASDAQ-TNMG), including Comps Fair Value.

Primary Valuation Read

Fair Value

$3.61

Estimated downside of 6.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$3.61

Comparable-company valuation reference.

Analyst Price Target

$112 2,794.1% Upside

Current consensus analyst target, where available.

How to read these valuation models

Use the 4 available valuation references for TNL Mediagene (NASDAQ-TNMG) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for TNL Mediagene (NASDAQ-TNMG)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

49.673 M

Current operating scale indicator.

Revenue Forecast

49.087 M

Forward revenue estimate.

EBITDA

-47.962 M

Current operating profitability reference.

EBITDA Forecast

-3.288 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review TNL Mediagene (NASDAQ-TNMG) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for TNL Mediagene (NASDAQ-TNMG)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

-6.89

No elevated caution signal from this screen.

Altman Z-Score

-36.1

Lower score that deserves closer risk review.

FCF / Net Income

13.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for TNL Mediagene (NASDAQ-TNMG). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for TNL Mediagene (NASDAQ-TNMG)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for TNL Mediagene (NASDAQ-TNMG). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

TNL Mediagene (NASDAQ-TNMG) Stock Forecast & Technical Outlook

Review TNL Mediagene (NASDAQ-TNMG) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for TNL Mediagene (NASDAQ-TNMG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for TNL Mediagene (NASDAQ-TNMG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for TNL Mediagene (NASDAQ-TNMG) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for TNL Mediagene (NASDAQ-TNMG) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for TNL Mediagene (NASDAQ-TNMG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for TNL Mediagene (NASDAQ-TNMG)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, TNL Mediagene (NASDAQ-TNMG) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

TNL Mediagene (NASDAQ-TNMG) Stock FAQ

Data-supported answers about TNL Mediagene (NASDAQ-TNMG), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$3.61
Estimated downside 6.8%
Valuation Rating
Overvalued
Estimated downside of 6.8%
Analyst Target
$112 2,794.1% Upside
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for TNL Mediagene (NASDAQ-TNMG) is $3.61. This implies an estimated downside of 6.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 6.8% versus the current market price.

The available analyst price target for TNL Mediagene (NASDAQ-TNMG) is $112 2,794.1% Upside.

The current financial health read for TNL Mediagene (NASDAQ-TNMG) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for TNL Mediagene (NASDAQ-TNMG).

The current market capitalization listed for TNL Mediagene is 1.237 M.

The current enterprise value listed for TNL Mediagene is 18.734 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for TNL Mediagene is NASDAQ-TNMG, and the stock is listed on NASDAQ.

TNL Mediagene (NASDAQ-TNMG) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for TNL Mediagene is 94.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for TNL Mediagene is 74.3%. Free float helps investors understand how much of the share base is available for public trading.